Kalpit Patel
Stock Analyst at Wolfe Research
(4.43)
# 1,195
Out of 4,974 analysts
219
Total ratings
38.2%
Success rate
16.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Upgraded: Buy | $23 | $16.44 | +39.90% | 1 | Aug 24, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $17.40 | - | 1 | Aug 16, 2026 | |
| KRYS Krystal Biotech | Reiterated: Hold | n/a | $336.68 | - | 2 | Aug 11, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $165 → $220 | $204.86 | +7.39% | 2 | Aug 10, 2026 | |
| ONC BeOne Medicines AG | Rated: Buy | $340 → $370 | $346.50 | +6.78% | 5 | Aug 9, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Sell | $50 | $110.82 | -54.88% | 4 | Jul 29, 2026 | |
| GMAB Genmab | Reiterated: Buy | $32 | $34.15 | -6.30% | 2 | Jun 14, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $35 | $23.89 | +46.50% | 1 | Jun 8, 2026 | |
| CGON CG Oncology | Reiterated: Hold | n/a | $72.55 | - | 2 | May 26, 2026 | |
| CTMX CytomX Therapeutics | Initiated Coverage: Buy | $6 | $2.69 | +123.05% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $145 | $93.90 | +54.42% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $25.43 | - | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $9.78 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $7.34 | +117.98% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $27.97 | n/a | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.02 | n/a | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $60 | $113.15 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $21.83 | n/a | 17 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $28 | $6.92 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $3.67 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $7.38 | n/a | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $24 | $44.36 | n/a | 10 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $29 | $18.09 | n/a | 9 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $2 | $1.31 | n/a | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $4.12 | n/a | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $15 | $3.62 | n/a | 5 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.71 | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $1.72 | n/a | 14 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $0.5853 | n/a | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $11.41 | n/a | 6 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $104.77 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.05 | n/a | 6 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.86 | n/a | 10 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $0.015 | n/a | 5 | Jun 7, 2022 |
Janux Therapeutics
Aug 24, 2026
Upgraded: Buy
Price Target: $23
Current: $16.44
Upside: +39.90%
Summit Therapeutics
Aug 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.40
Upside: -
Krystal Biotech
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $336.68
Upside: -
Revolution Medicines
Aug 10, 2026
Reiterated: Buy
Price Target: $165 → $220
Current: $204.86
Upside: +7.39%
BeOne Medicines AG
Aug 9, 2026
Rated: Buy
Price Target: $340 → $370
Current: $346.50
Upside: +6.78%
Corcept Therapeutics
Jul 29, 2026
Reiterated: Sell
Price Target: $50
Current: $110.82
Upside: -54.88%
Genmab
Jun 14, 2026
Reiterated: Buy
Price Target: $32
Current: $34.15
Upside: -6.30%
Tango Therapeutics
Jun 8, 2026
Upgraded: Buy
Price Target: $35
Current: $23.89
Upside: +46.50%
CG Oncology
May 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.55
Upside: -
CytomX Therapeutics
May 19, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.69
Upside: +123.05%
May 19, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $93.90
Upside: +54.42%
May 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $25.43
Upside: -
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $9.78
Upside: -
Oct 10, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $7.34
Upside: +117.98%
Jul 21, 2025
Reiterated: Buy
Price Target: $37
Current: $27.97
Upside: n/a
Jun 16, 2025
Reiterated: Buy
Price Target: $5
Current: $2.02
Upside: n/a
Jun 3, 2025
Upgraded: Buy
Price Target: $38 → $60
Current: $113.15
Upside: n/a
May 21, 2025
Reiterated: Hold
Price Target: $19
Current: $21.83
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $85 → $28
Current: $6.92
Upside: n/a
May 2, 2025
Reiterated: Hold
Price Target: $17 → $14
Current: $3.67
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $9
Current: $7.38
Upside: n/a
Mar 5, 2025
Reiterated: Hold
Price Target: $20 → $24
Current: $44.36
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $36 → $29
Current: $18.09
Upside: n/a
Feb 26, 2025
Downgraded: Hold
Price Target: $3.5 → $2
Current: $1.31
Upside: n/a
Jan 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $4.12
Upside: n/a
Nov 18, 2024
Reiterated: Hold
Price Target: $1 → $15
Current: $3.62
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $3
Current: $2.71
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $10 → $7
Current: $1.72
Upside: n/a
Aug 14, 2023
Reiterated: Buy
Price Target: $12 → $14
Current: $0.5853
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $7
Current: $11.41
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $104.77
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.05
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $2.86
Upside: n/a
Jun 7, 2022
Reiterated: Buy
Price Target: $12 → $6
Current: $0.015
Upside: n/a